Valantine Hannah

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$69,577.66
Insider Sells Quantity
4
Insider Sells Sum
$413,463.60

Insider Activity of Valantine Hannah

According to the SEC Form 4 filings, Valantine Hannah, being in a position of

  1. director at BridgeBio Pharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5830 shares for $220,724,
    over all time since 2021-12-28, has bought 5197 shares for $69,578, and sold 11660 shares for $413,464.

The largest purchase of all time was on 2021-12-28 and amounted to 3433 shares of BridgeBio Pharma, Inc. for $44,476.

The largest sale of all time was on 2024-01-16 and amounted to 2915 shares of BridgeBio Pharma, Inc. for $110,683.

Biography of Valantine Hannah

No biography is available at this moment.

2024-02-15SaleBridgeBio Pharma, Inc.
BBIO
director
2,915
0.0018%
$37.75$110,041-30.87%
2024-01-16SaleBridgeBio Pharma, Inc.
BBIO
director
2,915
0.0017%
$37.97$110,683-26.14%
2023-12-15SaleBridgeBio Pharma, Inc.
BBIO
director
2,915
0.0015%
$36.12$105,290-28.67%
2023-11-15SaleBridgeBio Pharma, Inc.
BBIO
director
2,915
0.0017%
$30.00$87,450-4.34%
2021-12-29PurchaseBridgeBio Pharma, Inc.
BBIO
director
1,764
0.0012%
$14.23$25,102-30.58%
2021-12-28PurchaseBridgeBio Pharma, Inc.
BBIO
director
3,433
0.0023%
$12.96$44,476
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.